$JLL

Ulbrich Christian sold $750K of JLL

Ulbrich Christian (CEO & President) sold 2,000 shares of JONES LANG LASALLE INC (JLL) at $375.00 ($0.75M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ulbrich Christian
Published Aug 17, 2026, 3:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 3:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JLL
Neutral
high confidence
Mentioned
$JLL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JLLNeutralLow
01

Why it matters

The newest fact is the specific sale size (2,000 shares), price ($375), and that it occurred under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 framing reduces the likelihood of a fundamental read-through.

03

What to watch

Because the sale is explicitly under a 10b5-1 plan, the disclosure is less informative about near-term company outlook than unscheduled sales or purchases.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-17, transaction dated 2026-08-14

Background

The article is a SEC Form 4 insider transaction disclosure for JLL by CEO and President Christian Ulbrich.

Company-level read

Ticker impact

$JLLNeutralHigh confidence
Context

JLL CEO Christian Ulbrich filed a Form 4 showing an open-market sale of 2,000 shares at $375 on 2026-08-14 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move based solely on this disclosure.

Evidence & confidence

The filing specifies a Rule 10b5-1 pre-arranged plan and an open-market sale; insider sales of this type are typically not interpreted as new negative information absent additional context.

Market effects

No sector-wide implications; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider selling can still reflect private liquidity needs or portfolio rebalancing, but traders may watch for follow-on sales or changes in selling patterns.

Key entities

  • JLL

    Jones Lang LaSalle Inc, issuer of the Form 4 insider transaction.

  • Christian Ulbrich

    CEO and President of JLL, reporting an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JLLLowAI 8/10

JLL advises on $856M in financing across The Millennium Residences and The Offices at Winthrop Center

JLL advised on $856M in financing for Winthrop Center, including a $281M C-PACE loan for The Millennium Residences and a $575M loan for The Offices at Winthrop Center. The project, developed by Millennium Partners, features 823,856 sq ft of office space and 317 luxury residential units. According to JLL, the financing reflects strong institutional lender interest in high-quality assets.

$JLLLow

JLL Developer’s $12M Fraud Suit Alleges Numbers Were Cooked to Fit the Loan

Jones Lang LaSalle Americas Inc. (JLL) is being sued for over $12M by a developer and property owner over allegedly inflated financial projections for a luxury apartment tower in Washington, D.C. The plaintiffs claim JLL revised net operating income projections upward to meet a lender's debt-yield requirement, leading to substantial financial losses. The property was sold for $30.5M, far below JLL's projected valuation.

$JLLMed

JLL stock hits all-time high at 374.16 USD

Jones Lang LaSalle (JLL) shares hit an all-time high of $374.16. The article cites market cap of $17.14B and P/E of 17.79, and says InvestingPro data flags the stock as undervalued versus fair value. It also reports Q2 2026 results: adjusted EPS $5.26 vs $4.52 expected, revenue $6.9B vs $6.74B, raised FY 2026 adjusted EPS guidance to $24.60-$25.90, and a Raymond James price target cut to $500 from $455.

$JLLMed

Jones Lang LaSalle Incorporated Q2 2026 Earnings Call Summary

Jones Lang LaSalle (JLL) reported Q2 2026 results driven by its “One JLL” strategy and resilient business lines. Management raised full-year 2026 adjusted EPS guidance to $24.60–$25.90 and targeted mid-to-high teens leasing and mid-teens capital markets revenue growth. It cited advisory revenue up 21%, office bifurcation, and risks from slower capital raising.